Prof Michael Herbst of CANSA was interviewed on SABC TV on the question of the exorbitant costs of cancer medications and the announcement by the Competition Commission of its probe into the pricing of several cancer medicines in South Africa.
Watch this short interview here.
Related
The Cancer Alliance represented by SECTION27 returned to court today in the matter of Cancer Alliance v the MEC for Health, Gauteng and 10 others. Today’s proceedings concerned an application for leave to appeal instituted by the provincial health respondents in...
SECTION27 and Cancer Alliance welcome Court judgment on the provision of lifesaving radiation oncology treatment for thousands of cancer patients SECTION27 and Cancer Alliance, welcome the judgment handed down today by the Johannesburg High Court in the...
For overpricing bone marrow cancer drug The Competition Commission has referred for prosecution to the Competition Tribunal (“Tribunal”), international drug manufacturer Celgene Corporation (“Celgene Corp”) and its subsidiary Celgene Logistics S.a.r.l (“Celgene...
